FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nicola Hanania

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Phenomena

Forced Expiratory Volume

Devices

Nebulizers and Vaporizers

Co-author Network

Publications

TOP 3
Nicola A Hanania; Jeffrey M Harris; Hsin-Ju Hsieh; Preeti Lal; Sofia Mosesova; Karin Rosén; Sally Wenzel; Joseph R Arron; David F Choy; William Busse
Exploring the effects of omalizumab in allergic asthma.
Amit D Parulekar; Ammar Alobaidy; Nicola A Hanania
Asthma outcomes revisited.
Nicola A Hanania
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nicola Hanania (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nicola A Hanania; Jeffrey M Harris; Hsin-Ju Hsieh; Preeti Lal; Sofia Mosesova; Karin Rosén; Sally Wenzel; Joseph R Arron; David F Choy; William Busse
Exploring the effects of omalizumab in allergic asthma.
American journal of respiratory and critical care medicine 2013;187(8):804-11.
2013: Amit D Parulekar; Ammar Alobaidy; Nicola A Hanania
Asthma outcomes revisited.
Current opinion in pulmonary medicine 2013;19(1):6-12.
2012: Nicola A Hanania
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide.
Respiratory medicine 2012;106 Suppl 2():S1-2.
2012: Nicola A Hanania; Frank Barnhart; Courtney Crim; Gregory Feldman; Sally Lettis; Lisa Sanford; Jae-Jeong Shim; Wolfgang Zachgo; Brett Haumann
The efficacy and safety of the novel long-acting β2 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial.
Chest 2012;142(1):119-27.
2012: Garbo Mak; Nicola A Hanania
New bronchodilators.
Current opinion in pharmacology 2012;12(3):238-45.
2012: Kristin Kuhl; Nicola A Hanania
Targeting IgE in asthma.
Current opinion in pulmonary medicine 2012;18(1):1-5.
2012: Nicola A Hanania; Andrea N Morris; Glenn D Crater; Amanda H Emmett; Dianne M O'Dell; Dennis E Niewoehner
Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD.
Respiratory medicine 2012;106(1):91-101.
2011: Nicola A Hanania; James F Donohue; Bartolome R Celli; Ubaldo J Martin
Bronchodilator reversibility in COPD.
Chest 2011;140(4):1055-63.
2011: Christina C Kao; Farrah Kheradmand; Venkata Bandi; Nicola A Hanania; Jean W-C Hsu; Farook Jahoor
Resting energy expenditure and protein turnover are increased in patients with severe chronic obstructive pulmonary disease.
Metabolism: clinical and experimental 2011;60(10):1449-55.
2011: Nicola A Hanania; Charles G Irvin; Monroe J King; Dennis K Ledford; John J Lima; Sameer K Mathur; Kushang V Patel; Joe W Ramsdell; Linda Rogers; Carol Saltoun; Mark F Sands; David A Stempel; Stephen I Wasserman; Sandra R Wilson; Robert Wise; Barbara P Yawn; Cynthia M Boyd; Sidney S Braman; Paul Enright; William B Ershler; Ann R Falsey; James E Fish; Ethan A Halm
Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop.
The Journal of allergy and clinical immunology 2011;128(3 Suppl):S4-24.
2011: Nicola A Hanania
Safety of chronic obstructive pulmonary disease medications: a primary care perspective.
Postgraduate medicine 2011;123(3):72-9.
2011: Nicola A Hanania; Hana Müllerova; Nicholas W Locantore; Jørgen Vestbo; Michael L Watkins; Emiel F M Wouters; Stephen I Rennard; Amir Sharafkhaneh
Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort.
American journal of respiratory and critical care medicine 2011;183(5):604-11.
2011: Nicola A Hanania; Amir Sharafkhaneh; Bartolome Celli; Marc Decramer; Ted Lystig; Steven Kesten; Donald Tashkin
Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial.
Respiratory research 2011;12():6.
2011: Garbo Mak; Nicola A Hanania
Vitamin D and asthma.
Current opinion in pulmonary medicine 2011;17(1):1-5.
2010: Nicola A Hanania; Gulshan Sharma; Amir Sharafkhaneh
COPD in the elderly patient.
Seminars in respiratory and critical care medicine 2010;31(5):596-606.
2010: Nicola A Hanania; B Mannava; A E Franklin; B J Lipworth; P A Williamson; W J Garner; Burton F Dickey; Richard A Bond
Response to salbutamol in patients with mild asthma treated with nadolol.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2010;36(4):963-5.
2010: Nicola A Hanania; David M Mannino; Barbara P Yawn; Douglas W Mapel; Fernando J Martinez; James F Donohue; Mark Kosinski; Regina Rendas-Baum; Matthew Mintz; Steven Samuels; Priti Jhingran; Anand A Dalal
Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ).
Respiratory medicine 2010;104(8):1160-70.
2010: Nicola A Hanania; James F Donohue; Harold Nelson; Kenneth Sciarappa; Elizabeth Goodwin; R A Baumgartner; J P Hanrahan
The safety and efficacy of arformoterol and formoterol in COPD.
COPD 2010;7(1):17-31.
2010: Amir Sharafkhaneh; Amarbir S Mattewal; Vinu M Abraham; Goutham Dronavalli; Nicola A Hanania
Budesonide/formoterol combination in COPD: a US perspective.
International journal of chronic obstructive pulmonary disease 2010;5():357-66.
2010: Amir Sharafkhaneh; Nancy J Petersen; Hong-Jen Yu; Anand A Dalal; Michael L Johnson; Nicola A Hanania
Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population.
International journal of chronic obstructive pulmonary disease 2010;5():125-32.
2010: Monroe King; Nicola A Hanania
Asthma in the elderly: current knowledge and future directions.
Current opinion in pulmonary medicine 2010;16(1):55-9.
2009: Donald P Tashkin; Nicola A Hanania; Joe McGinty; Kimberly Denis-Mize; Imtiaz Chaudry
Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease.
Advances in therapy 2009;26(11):1024-34.
2009: William C Bailey; Frank C Sciurba; Nicola A Hanania; James F Donohue; Gary T Ferguson; Joseph D Zibrak; Amir Sharafkhaneh; Philip Marcus; Kathleen Rosa; Elisabeth C Piault; Fernando J Martinez
Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ).
Primary care respiratory journal : journal of the General Practice Airways Group 2009;18(3):198-207.
2009: Nicola A Hanania; Ahmad Boota; Edward Kerwin; LaTanya Tomlinson; Kimberly Denis-Mize
Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.
Drugs 2009;69(9):1205-16.
2009: Long P Nguyen; Rui Lin; Sergio Parra; Ozozoma Omoluabi; Nicola A Hanania; Michael J Tuvim; Brian J Knoll; Burton F Dickey; Richard A Bond
Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(7):2435-40.
2008: Janet Maurer; Venkata Rebbapragada; Soo Borson; Roger Goldstein; Mark E Kunik; Abebaw Mengistu Yohannes; Nicola A Hanania
Anxiety and depression in COPD: current understanding, unanswered questions, and research needs.
Chest 2008;134(4 Suppl):43S-56S.
2008: James F Donohue; Nicola A Hanania; Charles Fogarty; S C Campbell; M Rinehart; K Denis-Mize
Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial.
Therapeutic advances in respiratory disease 2008;2(4):199-208.
2008: Mario Cazzola; Nicola A Hanania; Paul W Jones; Donald A Mahler; Barry Make; Jill Ohar; Stephen Rennard
It's about time--directing our attention toward modifying the course of COPD.
Respiratory medicine 2008;102 Suppl 1():S37-48.
2008: Amir Sharafkhaneh; Nicola A Hanania; Victor Kim
Pathogenesis of emphysema: from the bench to the bedside.
Proceedings of the American Thoracic Society 2008;5(4):475-7.
2008: Nicola A Hanania
Targeting airway inflammation in asthma: current and future therapies.
Chest 2008;133(4):989-98.
2008: James F Donohue; Nicola A Hanania; Ronald L Ciubotaru; Les Noe; David J Pasta; Kendyl Schaefer; Raymond Claus; William T Andrews; James Roach
Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Clinical therapeutics 2008;30 Spec No():989-1002.
2008: Nicola A Hanania
The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Pulmonary pharmacology & therapeutics 2008;21(3):540-50.
2008: Nicola A Hanania; Supria Singh; Rami El-Wali; Michael Flashner; Amie E Franklin; William J Garner; Burton F Dickey; Sergio Parra; Stephen Ruoss; Felix R Shardonofsky; Brian J O'Connor; Clive Page; Richard A Bond
The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study.
Pulmonary pharmacology & therapeutics 2008;21(1):134-41.
2007: Amir Sharafkhaneh; Suryakanta Velamuri; Vladimir Badmaev; Charlie Lan; Nicola A Hanania
The potential role of natural agents in treatment of airway inflammation.
Therapeutic advances in respiratory disease 2007;1(2):105-20.
2007: Nicola A Hanania
Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
Clinical therapeutics 2007;29(10):2121-33.
2007: Nicola A Hanania; James F Donohue
Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators.
Proceedings of the American Thoracic Society 2007;4(7):526-34.
2007: Nicola A Hanania; Amir Sharafkhaneh
Update on the pharmacologic therapy for chronic obstructive pulmonary disease.
Clinics in chest medicine 2007;28(3):589-607, vi-vii.
2007: Nicola A Hanania; Robert H Moore; Janice L Zimmerman; Charles T Miller; Remzi Bag; Amir Sharafkhaneh; Burton F Dickey
The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.
Respiratory medicine 2007;101(5):1007-14.
2007: Amir Sharafkhaneh; Tony G Babb; Todd M Officer; Nicola A Hanania; Hossein Sharafkhaneh; Aladin M Boriek
The confounding effects of thoracic gas compression on measurement of acute bronchodilator response.
American journal of respiratory and critical care medicine 2007;175(4):330-5.
2007: Robert H Moore; Ellen E Millman; Veronica Godines; Nicola A Hanania; Tuan M Tran; Hui Peng; Burton F Dickey; Brian J Knoll; Richard B Clark
Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization.
American journal of respiratory cell and molecular biology 2007;36(2):254-61.
2007: Nicola A Hanania
Revisiting asthma control: how should it best be defined?
Pulmonary pharmacology & therapeutics 2007;20(5):483-92.
2006: John J Lima; Janet T Holbrook; Jianwei Wang; James E Sylvester; Kathryn V Blake; Malcolm N Blumenthal; Mario Castro; Nicola A Hanania; Robert Wise
The C523A beta2 adrenergic receptor polymorphism associates with markers of asthma severity in African Americans.
The Journal of asthma : official journal of the Association for the Care of Asthma 2006;43(3):185-91.
2006: Nicola A Hanania; Robert L Atmar; Mario Castro
Influenza vaccine in patients with asthma.
Expert review of vaccines 2006;5(1):111-8.
2005: Nicola A Hanania; Nicolino Ambrosino; Peter Calverley; Mario Cazzola; Claudio F Donner; Barry Make
Treatments for COPD.
Respiratory medicine 2005;99 Suppl B():S28-40.
2005: Nicola A Hanania; Michael A Belfort
Acute asthma in pregnancy.
Critical care medicine 2005;33(10 Suppl):S319-24.
2005: Nicola A Hanania
The challenge of differentiating asthma from chronic obstructive pulmonary disease.
Managed care (Langhorne, Pa.) 2005;14(7 Suppl Obstructie Lung):9-15; discussion 24-6.
2005: Barry Make; Nicola A Hanania; Richard ZuWallack; Christopher Kalberg; Amanda Emmett; Christy P Brown; Katharine Knobil
The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.
Clinical therapeutics 2005;27(5):531-42.
2005: Francisco J Soto; Nicola A Hanania
Selective phosphodiesterase-4 inhibitors in chronic obstructive lung disease.
Current opinion in pulmonary medicine 2005;11(2):129-34.
2005: Nicola A Hanania; Christopher Kalberg; J Yates; Amanda Emmett; Donald Horstman; Katharine Knobil
The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD.
Pulmonary pharmacology & therapeutics 2005;18(1):19-22.
2004: Elizabeth S Guy; Ashok Kirumaki; Nicola A Hanania
Acute asthma in pregnancy.
Critical care clinics 2004;20(4):731-45, x.
2004: Nicola A Hanania; Robert H Moore
Anti-inflammatory activities of beta2-agonists.
Current drug targets. Inflammation and allergy 2004;3(3):271-7.
2004: Nicola A Hanania; Marianna M Sockrider; Mario Castro; Janet T Holbrook; James Tonascia; Robert Wise; Robert L Atmar
Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.
The Journal of allergy and clinical immunology 2004;113(4):717-24.
2003: Nicola A Hanania; Patrick Darken; Donald Horstman; Colin Reisner; Benjamin Lee; Suzanne Davis; Tushar Shah
The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.
Chest 2003;124(3):834-43.
2002: Nicola A Hanania; Amir Sharafkhaneh; Roger Barber; Burton F Dickey
Beta-agonist intrinsic efficacy: measurement and clinical significance.
American journal of respiratory and critical care medicine 2002;165(10):1353-8.
1999: Nicola A Hanania; Janice L Zimmerman
Accidental hypothermia.
Critical care clinics 1999;15(2):235-49.
1998: Nicola A Hanania; C Pope; Kalpalatha K Guntupalli
Acute respiratory distress syndrome. Inhaled nitric oxide.
Respiratory care clinics of North America 1998;4(4):695-709.
1998: S Jain; Nicola A Hanania; Kalpalatha K Guntupalli
Ventilation of patients with asthma and obstructive lung disease.
Critical care clinics 1998;14(4):685-705.
1998: Janice L Zimmerman; Nicola A Hanania
Vasodilators in mechanical ventilation.
Critical care clinics 1998;14(4):611-27.
1998: Nicola A Hanania; Susan M Tarlo; Frances Silverman; Bruce Urch; N Senathirajah; N Zamel; Paul Corey
Effect of exposure to low levels of ozone on the response to inhaled allergen in allergic asthmatic patients.
Chest 1998;114(3):752-6.